A 250 mcg dose requires 1.25 mL, which exceeds the capacity of a standard 1 mL insulin syringe
Reconstitute it with a fixed volume of bacteriostatic water so the concentration lands where the protocol expects
Safety analyses included all participants who received at least one dose of the assigned intervention, with results summarized descriptively [1]
Not intended for human consumption, clinical use, or as a drug, food, cosmetic, or medical device
The results showed that liraglutide had a modest positive effect on improving motor function and performed well in terms of safety and tolerability, although there were some manageable gastrointestinal side effects
Others use abdominal or deltoid sites for systemic delivery